Caspofungin

被引：17

作者：

Chandrasekar, PH ^{[1
]}

Manavathu, EK ^{[1
]}

机构：

[1] Wayne State Univ, Dept Med, Div Infect Dis, Detroit, MI 48201 USA

来源：

DRUGS OF TODAY | 2002年 / 38卷 / 12期

关键词：

D O I：

10.1358/dot.2002.38.12.820101

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Available systemically effective antifungal agents for the treatment of invasive fungal infections are few. With the increasing recognition of a need for newer antifungal drugs, caspofungin has been introduced as the first member of a new class of compounds called echinocandins. This paper reviews the chemistry and mechanism of action of caspofungin, its activity in vitro and in animal models, and clinical pharmacokinetics, clinical efficacy and safety in patients. (C) 2002 Prous Science. All rights reserved.

引用

页码：829 / 846

页数：18

共 90 条

[1] Efficacy of the echinocandin caspofungin against disseminated aspergillosis and candidiasis in cyclophosphamide-induced immunosuppressed mice
Abruzzo, GK
Gill, CJ
Flattery, AM
Kong, L
Leighton, C
Smith, JG
Pikounis, VB
Bartizal, K
Rosen, H
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (09) : 2310 - 2318
[2] Evaluation of the echinocandin antifungal MK-0991 (L-743,872): Efficacies in mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis
Abruzzo, GK
Flattery, AM
Gill, CJ
Kong, L
Smith, JG
Pikounis, VB
Balkovec, JM
Bouffard, AF
Dropinski, JF
Rosen, H
Kropp, H
Bartizal, K
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (11) : 2333 - 2338
[3] EVALUATION OF WATER-SOLUBLE PNEUMOCANDIN ANALOGS L-733560, L-705589, AND L-731373 WITH MOUSE MODELS OF DISSEMINATED ASPERGILLOSIS, CANDIDIASIS, AND CRYPTOCOCCOSIS
ABRUZZO, GK
FLATTERY, AM
GILL, CJ
KONG, L
SMITH, JG
KRUPA, D
PIKOUNIS, VB
KROPP, H
BARTIZAL, K
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (05) : 1077 - 1081
[4] Randomized, double-blind, Multicenter study of caspofungin versus amphotericin B for treatment of oropharyngeal and esophageal candidiases
Arathoon, EG
Gotuzzo, E
Noriega, LM
Berman, RS
DiNubile, MJ
Sable, CA
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (02) : 451 - 457
[5] In vitro synergy of caspofungin and amphotericin B against Aspergillus and Fusarium spp.
Arikan, S
Lozano-Chiu, M
Paetznick, V
Rex, JH
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (01) : 245 - 247
[6] In vitro susceptibility testing methods for caspofungin against Aspergillus and Fusarium isolates
Arikan, S
Lozano-Chiu, M
Paetznick, V
Rex, JH
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (01) : 327 - 330
[7] Balani SK, 2000, DRUG METAB DISPOS, V28, P1274
[8] SYNTHESIS, STABILITY, AND BIOLOGICAL EVALUATION OF WATER-SOLUBLE PRODRUGS OF A NEW ECHINOCANDIN LIPOPEPTIDE - DISCOVERY OF A POTENTIAL CLINICAL AGENT FOR THE TREATMENT OF SYSTEMIC CANDIDIASIS AND PNEUMOCYSTIS-CARINII PNEUMONIA (PCP)
BALKOVEC, JM
BLACK, RM
HAMMOND, ML
HECK, JV
ZAMBIAS, RA
ABRUZZO, G
BARTIZAL, K
KROPP, H
TRAINOR, C
SCHWARTZ, RE
MCFADDEN, DC
NOLLSTADT, KH
PITTARELLI, LA
POWLES, MA
SCHMATZ, DM
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (01) : 194 - 198
[9] IN-VITRO EVALUATION OF THE PNEUMOCANDIN ANTIFUNGAL AGENT L-733560, A NEW WATER-SOLUBLE HYBRID OF L-705589 AND L-731373
BARTIZAL, K
SCOTT, T
ABRUZZO, GK
GILL, CJ
PACHOLOK, C
LYNCH, L
KROPP, H
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (05) : 1070 - 1076
[10] In vitro preclinical evaluation studies with the echinocandin antifungal MK-0991 (L-743,872)
Bartizal, K
Gill, CJ
Abruzzo, GK
Flattery, AM
Kong, L
Scott, PM
Smith, JG
Leighton, CE
Bouffard, A
Dropinski, JF
Balkovec, J
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (11) : 2326 - 2332

← 1 2 3 4 5 6 7 8 9 →